You are here: Home » News-CM » Companies » Results
Business Standard

Jenburkt Pharmaceuticals standalone net profit rises 4.04% in the December 2019 quarter

Capital Market 

Sales rise 4.06% to Rs 33.59 crore

Net profit of Jenburkt Pharmaceuticals rose 4.04% to Rs 4.64 crore in the quarter ended December 2019 as against Rs 4.46 crore during the previous quarter ended December 2018. Sales rose 4.06% to Rs 33.59 crore in the quarter ended December 2019 as against Rs 32.28 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales33.5932.28 4 OPM %19.7719.70 -PBDT7.336.92 6 PBT6.676.57 2 NP4.644.46 4

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, February 08 2020. 16:48 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU